Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML

Abstract Chemoresistance poses a significant impediment to effective treatment strategies for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Our previous study unveiled that oncogene TWIST1 interacted with DNA methyltransferase 3a (DNMT3a) to regulate the decitabine (DAC) resistan...

Full description

Bibliographic Details
Main Authors: Hongjiao Li, Yi Wang, Shuang Feng, Kaijing Chang, Xinwen Yu, Fenfang Yang, Haozhe Huang, Yuanbo Wang, Xiang Li, Feng Guan
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Cell Communication and Signaling
Subjects:
Online Access:https://doi.org/10.1186/s12964-023-01278-y
_version_ 1797557714623135744
author Hongjiao Li
Yi Wang
Shuang Feng
Kaijing Chang
Xinwen Yu
Fenfang Yang
Haozhe Huang
Yuanbo Wang
Xiang Li
Feng Guan
author_facet Hongjiao Li
Yi Wang
Shuang Feng
Kaijing Chang
Xinwen Yu
Fenfang Yang
Haozhe Huang
Yuanbo Wang
Xiang Li
Feng Guan
author_sort Hongjiao Li
collection DOAJ
description Abstract Chemoresistance poses a significant impediment to effective treatment strategies for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Our previous study unveiled that oncogene TWIST1 interacted with DNA methyltransferase 3a (DNMT3a) to regulate the decitabine (DAC) resistance in MDS/AML. However, the underlying mechanism of TWIST1 dysregulation in DAC resistance remained enigmatic. Here, we found that O-GlcNAc modification was upregulated in CD34+ cells from MDS/AML patients who do not respond to DAC treatment. Functional study revealed that O-GlcNAcylation could stabilize TWIST1 by impeding its interaction with ubiquitin E3 ligase CBLC. In addition, as one typical transcription factor, TWIST1 could bind to the promoter of O-GlcNAc transferase (OGT) gene and activate its transcription. Collectively, we highlighted the crucial role of the O-GlcNAcylated TWIST1 in the chemoresistance capacity of MDS/AML clonal cells, which may pave the way for the development of a new therapeutic strategy targeting O-GlcNAcylated proteins and reducing the ratio of MDS/AML relapse. Video Abstract
first_indexed 2024-03-10T17:20:16Z
format Article
id doaj.art-5a1b2ef9ca984599a29c15dd73d48436
institution Directory Open Access Journal
issn 1478-811X
language English
last_indexed 2024-03-10T17:20:16Z
publishDate 2023-09-01
publisher BMC
record_format Article
series Cell Communication and Signaling
spelling doaj.art-5a1b2ef9ca984599a29c15dd73d484362023-11-20T10:22:06ZengBMCCell Communication and Signaling1478-811X2023-09-0121111210.1186/s12964-023-01278-yReciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AMLHongjiao Li0Yi Wang1Shuang Feng2Kaijing Chang3Xinwen Yu4Fenfang Yang5Haozhe Huang6Yuanbo Wang7Xiang Li8Feng Guan9Key Laboratory of Resource Biology and Biotechnology Western China, Ministry of Education; Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest UniversityDepartment of Hematology, Provincial People’s HospitalKey Laboratory of Resource Biology and Biotechnology Western China, Ministry of Education; Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest UniversityKey Laboratory of Resource Biology and Biotechnology Western China, Ministry of Education; Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest UniversityKey Laboratory of Resource Biology and Biotechnology Western China, Ministry of Education; Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest UniversityKey Laboratory of Resource Biology and Biotechnology Western China, Ministry of Education; Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest UniversityKey Laboratory of Resource Biology and Biotechnology Western China, Ministry of Education; Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest UniversityKey Laboratory of Resource Biology and Biotechnology Western China, Ministry of Education; Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest UniversityInstitute of Hematology, School of Medicine, Northwest UniversityKey Laboratory of Resource Biology and Biotechnology Western China, Ministry of Education; Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest UniversityAbstract Chemoresistance poses a significant impediment to effective treatment strategies for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Our previous study unveiled that oncogene TWIST1 interacted with DNA methyltransferase 3a (DNMT3a) to regulate the decitabine (DAC) resistance in MDS/AML. However, the underlying mechanism of TWIST1 dysregulation in DAC resistance remained enigmatic. Here, we found that O-GlcNAc modification was upregulated in CD34+ cells from MDS/AML patients who do not respond to DAC treatment. Functional study revealed that O-GlcNAcylation could stabilize TWIST1 by impeding its interaction with ubiquitin E3 ligase CBLC. In addition, as one typical transcription factor, TWIST1 could bind to the promoter of O-GlcNAc transferase (OGT) gene and activate its transcription. Collectively, we highlighted the crucial role of the O-GlcNAcylated TWIST1 in the chemoresistance capacity of MDS/AML clonal cells, which may pave the way for the development of a new therapeutic strategy targeting O-GlcNAcylated proteins and reducing the ratio of MDS/AML relapse. Video Abstracthttps://doi.org/10.1186/s12964-023-01278-yTWIST1OGTO-GlcNAcDAC resistanceMDS/AML
spellingShingle Hongjiao Li
Yi Wang
Shuang Feng
Kaijing Chang
Xinwen Yu
Fenfang Yang
Haozhe Huang
Yuanbo Wang
Xiang Li
Feng Guan
Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
Cell Communication and Signaling
TWIST1
OGT
O-GlcNAc
DAC resistance
MDS/AML
title Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
title_full Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
title_fullStr Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
title_full_unstemmed Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
title_short Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
title_sort reciprocal regulation of twist1 and ogt determines the decitabine efficacy in mds aml
topic TWIST1
OGT
O-GlcNAc
DAC resistance
MDS/AML
url https://doi.org/10.1186/s12964-023-01278-y
work_keys_str_mv AT hongjiaoli reciprocalregulationoftwist1andogtdeterminesthedecitabineefficacyinmdsaml
AT yiwang reciprocalregulationoftwist1andogtdeterminesthedecitabineefficacyinmdsaml
AT shuangfeng reciprocalregulationoftwist1andogtdeterminesthedecitabineefficacyinmdsaml
AT kaijingchang reciprocalregulationoftwist1andogtdeterminesthedecitabineefficacyinmdsaml
AT xinwenyu reciprocalregulationoftwist1andogtdeterminesthedecitabineefficacyinmdsaml
AT fenfangyang reciprocalregulationoftwist1andogtdeterminesthedecitabineefficacyinmdsaml
AT haozhehuang reciprocalregulationoftwist1andogtdeterminesthedecitabineefficacyinmdsaml
AT yuanbowang reciprocalregulationoftwist1andogtdeterminesthedecitabineefficacyinmdsaml
AT xiangli reciprocalregulationoftwist1andogtdeterminesthedecitabineefficacyinmdsaml
AT fengguan reciprocalregulationoftwist1andogtdeterminesthedecitabineefficacyinmdsaml